Applied Therapeutics Inc (NASDAQ:APLT) has coverage initiated with a Buy rating

Analyst Ratings For Applied Therapeutics Inc (NASDAQ:APLT)

Story continues below

Today, Citigroup initiated coverage on Applied Therapeutics Inc (NASDAQ:APLT) with a Buy.

There are 4 Buy Ratings, no Strong Buy Ratings, no Sell Ratings, no Hold Ratings on the stock.

The current consensus rating on Applied Therapeutics Inc (NASDAQ:APLT) is Buy with a consensus target price of N/A per share, a potential N/A.

Some recent analyst ratings include

  • 6/10/2019-Applied Therapeutics Inc (NASDAQ:APLT) has coverage initiated with a Buy rating
  • 6/10/2019-Applied Therapeutics Inc (NASDAQ:APLT) has coverage initiated with a Outperform rating
  • 6/10/2019-Applied Therapeutics Inc (NASDAQ:APLT) has coverage initiated with a Buy rating
  • 6/10/2019-Applied Therapeutics Inc (NASDAQ:APLT) has coverage initiated with a Outperform rating

    Recent Trading Activity for Applied Therapeutics Inc (NASDAQ:APLT)
    Shares of Applied Therapeutics Inc closed the previous trading session at 9.30 up +0.20 2.20% with 8.94 shares trading hands.

    An ad to help with our costs